Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP721758.RApRl1NwxvCJxf7Vu1JNhg1YtgCh5_R_5WRGLXSMQaJRo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP721758.RApRl1NwxvCJxf7Vu1JNhg1YtgCh5_R_5WRGLXSMQaJRo130_assertion type Assertion NP721758.RApRl1NwxvCJxf7Vu1JNhg1YtgCh5_R_5WRGLXSMQaJRo130_head.
- NP721758.RApRl1NwxvCJxf7Vu1JNhg1YtgCh5_R_5WRGLXSMQaJRo130_assertion description "[Amplification of the ERBB-2 gene as determined by FISH was observed in 3/7 (43%) carcinosarcomas with 2+ or 3+ overexpression, resulting in an overall 3/22 (14%) amplification rate.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721758.RApRl1NwxvCJxf7Vu1JNhg1YtgCh5_R_5WRGLXSMQaJRo130_provenance.
- NP721758.RApRl1NwxvCJxf7Vu1JNhg1YtgCh5_R_5WRGLXSMQaJRo130_assertion evidence source_evidence_literature NP721758.RApRl1NwxvCJxf7Vu1JNhg1YtgCh5_R_5WRGLXSMQaJRo130_provenance.
- NP721758.RApRl1NwxvCJxf7Vu1JNhg1YtgCh5_R_5WRGLXSMQaJRo130_assertion SIO_000772 15581967 NP721758.RApRl1NwxvCJxf7Vu1JNhg1YtgCh5_R_5WRGLXSMQaJRo130_provenance.
- NP721758.RApRl1NwxvCJxf7Vu1JNhg1YtgCh5_R_5WRGLXSMQaJRo130_assertion wasDerivedFrom befree-20140225 NP721758.RApRl1NwxvCJxf7Vu1JNhg1YtgCh5_R_5WRGLXSMQaJRo130_provenance.
- NP721758.RApRl1NwxvCJxf7Vu1JNhg1YtgCh5_R_5WRGLXSMQaJRo130_assertion wasGeneratedBy ECO_0000203 NP721758.RApRl1NwxvCJxf7Vu1JNhg1YtgCh5_R_5WRGLXSMQaJRo130_provenance.